Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Bayer
< Previous
1
2
3
4
5
6
Next >
Bayer and Thermo Fisher Scientific Collaborate to Increase Patient Access to Precision Cancer Medicines
March 20, 2024
From
Bayer
Via
Business Wire
Bayer Pharmaceuticals streamlines Leadership Team for next phase of growth
March 20, 2024
From
Bayer
Via
Business Wire
Positive topline results from Phase III long-term study OASIS 3 support submissions for marketing authorization for Bayer’s elinzanetant
March 19, 2024
From
Bayer
Via
Business Wire
Bayer Wins Third Consecutive Trial Victory
March 05, 2024
From
Bayer
Via
Business Wire
Bayer Receives U.S. FDA Breakthrough Therapy Designation for BAY 2927088 for Non-Small Cell Lung Cancer Harboring HER2 Activating Mutations
February 26, 2024
From
Bayer
Via
Business Wire
Bayer initiates Phase II study with first-in-class anti-alpha2 antiplasmin antibody in patients with deep vein thrombosis
February 20, 2024
From
Bayer
Via
Business Wire
First Patient Randomized in AskBio Phase II Gene Therapy Trial for Congestive Heart Failure
February 16, 2024
From
Bayer
Via
Business Wire
Bayer Unveils Groundbreaking Solar Energy Projects at Sites in New Jersey and California
January 23, 2024
From
Bayer
Via
Business Wire
Bayer appoints Nelson Ambrogio as new Head of Radiology Business at Pharmaceuticals Division
January 22, 2024
From
Bayer
Via
Business Wire
MiraLAX® Exposes The Gut Gap™, Proving Women are More Stressed and More Constipated than Men
January 17, 2024
From
Bayer
Via
Business Wire
Bayer Reveals Latest Prostate Cancer Data at 2024 ASCO GU Cancers Symposium
January 17, 2024
From
Bayer
Via
Business Wire
Bayer starts Phase II study NIRVANA to evaluate elinzanetant in women with sleep disturbances associated with menopause
January 08, 2024
From
Bayer
Via
Business Wire
Bayer’s elinzanetant meets all primary and key secondary endpoints in pivotal OASIS 1 and 2 Phase III studies
January 08, 2024
From
Bayer
Via
Business Wire
Bayer Statement on Win in Jones Roundup™ Trial
December 27, 2023
From
Bayer
Via
Business Wire
Bayer and Salus Optima Partner on AI-Enabled Healthy Aging Journey
December 07, 2023
From
Bayer
Via
Business Wire
Bayer Earns Top Score in Human Rights Campaign Foundation’s 2023-2024 Corporate Equality Index for Sixth Consecutive Year
December 05, 2023
From
Bayer
Via
Business Wire
Bayer and CrossBay Medical to develop novel Intrauterine System Inserter
November 30, 2023
From
Bayer
Via
Business Wire
Bayer and Hurdle launch precision health strategic partnership
November 28, 2023
From
Bayer
Via
Business Wire
Bayer Announces Publication of Health Economic Model Evaluation at RSNA, Providing New Insights Into Cost Effectiveness and Capacity Needs of Supplemental Screening Modalities for Dense Breasts
November 27, 2023
From
Bayer
Via
Business Wire
Bayer Championing Advancements in Radiology Pipeline and Accelerating AI Innovation
November 22, 2023
From
Bayer
Via
Business Wire
Bayer Issues Voluntary Recall Nationwide of VITRAKVI® (larotrectinib) Oral Solution 20 mg/mL Due to Presence of Microbial Contamination
November 17, 2023
From
Bayer
Via
Business Wire
Bayer Provides Update on Aliqopa® (copanlisib)
November 13, 2023
From
Bayer
Via
Business Wire
New asundexian Phase III study to include patients with atrial fibrillation ineligible for oral anticoagulant treatment
November 10, 2023
From
Bayer
Via
Business Wire
Bayer and Recursion focus research collaboration on Oncology
November 09, 2023
From
Bayer
Via
Business Wire
Alka-Seltzer® Teams Up with George Kittle to Encourage Football Fans to ‘Say Yes’ to Going Big on Game Days
November 09, 2023
From
Bayer
Via
Business Wire
New Interim, Real-World Data Provides Additional Insights on Hyperkalemia and Safety of Kerendia® (finerenone) for Patients with Chronic Kidney Disease Associated with Type 2 Diabetes
November 04, 2023
From
Bayer
Via
Business Wire
New Human Biomarker Findings Support Mechanism of Action of Kerendia® (finerenone) in Patients with Chronic Kidney Disease Associated with Type 2 Diabetes
November 02, 2023
From
Bayer
Via
Business Wire
Bayer and Broad Institute of MIT and Harvard Extend Research Collaboration to Develop New Cancer Therapies
November 02, 2023
From
Bayer
Via
Business Wire
FieldView and Combyne Platform Integration Helps Farmers Better Manage Grain Marketing and Build Profitability Insights
October 30, 2023
From
Bayer
Via
Business Wire
Bayer Unveils Latest Data from Oncology Portfolio at ESMO Congress 2023
October 12, 2023
From
Bayer
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.